p63 expression in ovarian tumours: Immunopositivity in metastatic transitional cell carcinoma of the ovary

Histopathology

Volumn 53, Issue 2, 2008, Pages 228-

  Kalebi, A ^a   Hale, M ^a  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKERATIN 20; CYTOKERATIN 7; PROTEIN P63;

AGED; CANCER STAGING; CASE REPORT; CLINICAL FEATURE; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; KIDNEY PELVIS TUMOR; LETTER; NEPHRECTOMY; OVARY CARCINOMA; OVARY CELL; OVARY TUMOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSITIONAL CELL CARCINOMA;

AGED; CARCINOMA, TRANSITIONAL CELL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; OVARIAN NEOPLASMS; TRANS-ACTIVATORS; TUMOR SUPPRESSOR PROTEINS; URINARY BLADDER NEOPLASMS;

EID: 47749101280     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2008.03066.x     Document Type: Letter

References (3)

1. Liao XY, Xue WC, Shen DH, Ngan HY, Siu MK, Cheung AN. p63 expression in ovarian tumours: a marker for Brenner tumours but not transitional cell carcinomas. Histopathology 2007 51 477 483.
2. Logani S, Oliva E, Amin MB, Folpe AL, Cohen C, Young RH. Immunoprofile of ovarian tumors with putative transitional cell (urothelial) differentiation using novel urothelial markers: histogenetic and diagnostic implications. Am. J. Surg. Pathol. 2003 27 1434 1441.
3. McCluggage WG, Wilkinson N. Metastatic neoplasms involving the ovary: a review with an emphasis on morphological and immunohistochemical features. Histopathology 2005 47 231 247.